Analysis of hepatitis B virus X gene phylogeny, genetic variability and its impact on pathogenesis: Implications in Eastern Indian HBV carriers

Virology

Volumn 382, Issue 2, 2008, Pages 190-198

  Datta, Sibnarayan ^a   Banerjee, Arup ^a   Chandra, Partha Kumar ^a   Biswas, Avik ^a   Panigrahi, Rajesh ^a   Mahapatra, Pradip Kumar ^b   Panda, Chinmoy Kumar ^c   Chakrabarti, Shekhar ^a,d   Bhattacharya, Sujit Kumar ^a,d   Chakravarty, Runu ^a  

^a INDIAN COUNCIL OF MEDICAL RESEARCH   (India)

^b JADAVPUR UNIVERSITY   (India)

^c CHITTARANJAN NATIONAL CANCER INSTITUTE   (India)

^d NATIONAL INSTITUTE OF CHOLERA AND ENTERIC DISEASES   (India)

Author keywords

Eastern India; HBV DNA; Hepatitis B genotypes; Mutation; X gene

Indexed keywords

DEOXYRIBONUCLEASE I;

ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; DISEASE CARRIER; ETHNIC GROUP; GENE MUTATION; GENETIC VARIABILITY; GENOTYPE; HEPATITIS B VIRUS; HUMAN; INDIA; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PHYLOGENY; POPULATION RESEARCH; PRIORITY JOURNAL;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; BASE SEQUENCE; CARRIER STATE; CONSENSUS SEQUENCE; DNA, VIRAL; EVOLUTION, MOLECULAR; GENETIC VARIATION; GENOTYPE; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; INDIA; MOLECULAR SEQUENCE DATA; PHYLOGENY; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN STRUCTURE, TERTIARY; SEQUENCE HOMOLOGY, AMINO ACID; TRANS-ACTIVATORS; VIRULENCE;

HEPATITIS B VIRUS;

EID: 56749157985     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2008.09.007     Document Type: Article

References (54)

1. Banerjee A., Kurbanov F., Datta S., Chandra P.K., Tanaka Y., Mizokami M., and Chakravarty R. Phylogenetic relatedness and genetic diversity of hepatitis B virus isolates in Eastern India. J. Med. Virol. 78 (2006) 1164-1174
2. Banerjee A., Datta S., Chandra P.K., Roychowdhury S., Panda C.K., and Chakravarty R. Distribution of hepatitis B virus genotypes: phylogenetic analysis and virological characteristics of genotype C circulating among HBV carriers in Kolkata, Eastern India. World J. Gastroenterol. 12 (2006) 5964-5971
3. Bouchard M.J., and Schneider R.J. The enigmatic X gene of hepatitis B virus. J. Virol. 78 (2004) 12725-12734
4. Cabrerizo M., Bartolome J., DeSequera P., Caramelo C., and Carreno V. Hepatitis B virus DNA in serum and blood cells of hepatitis B surface antigen-negative hemodialysis patients and staff. J. Am. Soc. Nephrol. 8 (1997) 1443-1447
5. Cabrerizo M., Bartolome J., Inigo E.R., Lopez-Alcorocho J.M., Cotonat T., and Carreno V. Analysis of the hepatitis B virus precore and ORF-X sequences in patients with antibody to hepatitis B e antigen with and without normal ALT levels. J. Med. Virol. 56 (1998) 294-299
6. Colgrove R., Simon G., and Ganem D. Transcriptional activation of homologous and heterologous genes by the hepatitis B virus X gene product in cells permissive for viral replication. J. Virol. 63 (1989) 4019-4026
7. Datta S., Banerjee A., Chandra P.K., Mahapatra P.K., Chakrabarti S., and Chakravarty R. Drug trafficking routes and hepatitis B in injection drug users, Manipur, India. Emerg. Infect. Dis. 12 (2006) 1954-1957
8. Datta S., Banerjee A., Chandra P.K., and Chakravarty R. Pin1-HBx interaction: a step towards understanding the significance of HBV genotypes in hepatocarcinogenesis. Gastroenterology 133 (2007) 727-728
9. De Oliveira D.E. DNA viruses in human cancer: an integrated overview on fundamental mechanisms of viral carcinogenesis. Cancer Lett. 247 (2007) 182-196
10. Fleischhacker M., and Schmidt B. Circulating nucleic acids (CNAs) and cancer-a survey. Biochim. Biophys. Acta 1775 (2007) 181-232
11. Gandhe S.S., Chadha M.S., and Arankalle V.A. Hepatitis B virus genotypes and serotypes in Western India: lack of clinical significance. J. Med. Virol. 63 (2003) 324-330
12. Gunther S., Sommer G., Iwanska A., and Will H. Heterogeneity and common features of defective hepatitis B virus genomes derived from spliced pregenomic RNA. Virology 238 (1997) 363-371
13. Hall T.A. BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucl. Acids Symp. Ser. 41 (1999) 95-98
14. Hussain S.P., Schwank J., Staib F., Wang X.W., and Harris C.C. TP53 mutations and hepatocellular carcinoma: insights into the etiology and pathogenesis of liver cancer. Oncogene 26 (2007) 2166-2176
15. Iavarone M., Trabut J.B., Delpeuch O., Carnot F., Colombo M., Kremsdorf D., Brechot C., and Theirs V. Characterisation of hepatitis B virus X protein mutants in tumour and non-tumour liver cells using capture microdissection. J. Hepatol. 39 (2003) 253-261
16. Kao J.H. Hepatitis B virus genotypes and hepatocellular carcinoma in Taiwan. Intervirology 46 (2003) 400-407
17. Katiyar S., Dash B.C., Thakur V., Guptan R.C., Sarin S.K., and Das B.C. p53 tumor suppressor gene mutations in hepatocellular carcinoma patients in India. Cancer 88 (2000) 1565-1573
18. Kidd-Ljunggren K., Oberg M., and Kidd A.H. The hepatitis B virus X gene: analysis of functional domain variation and gene phylogeny using multiple sequences. J. Gen. Virol. 76 (1995) 2119-2130
19. Kim H.J., Park J.H., Jee Y., Lee S.A., Kim H., Song B.C., Yang S.Y., Lee M.H., Yoon J.H., Kim H.J., Lee H.S., Hwang E.S., Kook Y.H., and Kim B.J. Hepatitis B virus X mutations occurring naturally associated with clinical severity of liver disease among Korean patients with chronic genotype C infection. J. Med. Virol. 80 (2008) 1337-1343
20. Korber B., and Myers G. Signature pattern analysis: a method for assessing viral sequence relatedness. AIDS Res. Hum. Retroviruses 8 (1992) 1549-1560
21. Kramvis A., and Kew M. The core promoter of hepatitis B virus. J. Viral. Hepat. 6 (1999) 415-427
22. Kumar S., Tamura K., and Nei M. MEGA3: integrated software for molecular evolutionary genetics analysis and sequence alignment. Brief Bioinformat. 5 (2004) 150-163
23. Kwun H.J., and Jang K.L. Natural variants of hepatitis B virus X protein have differential effects on the expression of cyclin-dependent kinase inhibitor p21 gene. Nucleic Acids Res. 32 (2004) 2202-2213
24. Kyte J., and Doolittle R.F. A simple method for displaying the hydropathic character of a protien. J. Mol. Biol. 157 (1982) 105
25. Lee G.H., Wasser S., and Lim S.G. Hepatitis B pregenomic RNA splicing-the products, the regulatory mechanisms and its biological significance. Virus. Res. 136 (2008) 1-7
26. Lin X., Xu X., Huang Q.L., Liu Y.Q., Zheng D.L., Chen W.N., and Lin J.Y. Biological impacts of "hot-spot" mutations of hepatitis B virus X proteins are genotype B and C differentiated. World J. Gastroenterol. 11 (2005) 4703-4708
27. Liu X.H., Lin J., Zhang S.H., Zhang S.M., Feitelson M.A., Gao H.J., and Zhu M.H. COOH-terminal deletion of HBx gene is a frequent event in HBV-associated hepatocellular carcinoma. World J. Gastroenterol. 14 (2008) 1346-1352
28. Madden C.R., Finegold M.J., and Slagle B.L. Altered DNA mutation spectrum in aflatoxin B1-treated transgenic mice that express the hepatitis B virus X protein. J. Virol. 76 (2002) 11770-11774
29. Märschenz S., Endres A.S., Brinckmann A., Heise T., Kristiansen G., Nürnberg P., Krüger D.H., Günther G., and Meisel H. Functional analysis of complex hepatitis B virus variants associated with development of liver cirrhosis. Gastroenterology 131 (2006) 765-780
30. Minemura M., Shimizu Y., Hirano K., Nakayama Y., Tokimitsu Y., Tajiri K., Yamada K., Xue F., Takahara T., Watanabe A., and Sugiyama T. Functional analysis of transactivation by mutants of hepatitis B virus X gene in human hepatocellular carcinoma. Oncol. Rep. 14 (2005) 495-499
31. Muroyama R., Kato N., Yoshida H., Otsuka M., Moriyama M., Wang Y., Shao R.X., Dharel N., Tanaka Y., Ohta M., Tateishi R., Shiina S., Tatsukawa M., Fukai K., Imazeki F., Yokosuka O., Shiratori Y., and Omata M. Nucleotide change of codon 38 in the X gene of hepatitis B virus genotype C is associated with an increased risk of hepatocellular carcinoma. J. Hepatol. 45 (2006) 805-812
32. Nei M., and Gojobori T. Simple methods for estimating the numbers of synonymous and nonsynonymous nucleotide substitutions. Mol. Biol. Evol. 3 (1986) 418-426
33. Noh E.J., Jung H.J., Jeong G., Choi K.S., Park H.J., Lee C.H., and Lee J.S. Subcellular localization and transcriptional repressor activity of HBx on p21WAF1/Cip1 promoter is regulated by ERK-mediated phosphorylation. Biochem. Biophys. Res. Comm. 319 (2004) 738-745
34. Norder H., Courouce A.M., Coursaget P., Echevarria J.M., Lee S.D., Mushahwar I.K., Robertson B.H., Locarnini S., and Magnius L.O. Genetic diversity of hepatitis B virus strains derived worldwide: genotypes, subgenotypes, and HBsAg subtypes. Intervirology 47 (2004) 289-309
35. Osiowy C. Detection of HBsAg mutants. J. Med. Virol. 78 (2006) S48-S51
36. Pang R., Lee T.K., Poon R.T., Fan S.T., Wong K.B., Kwong Y.L., and Tse E. Pin1 interacts with a specific serine-proline motif of hepatitis B virus X-protein to enhance hepatocarcinogenesis. Gastroenterology 132 (2007) 1088-1103
37. Park O.Y., Jin Y.H., Lee M., Shin H.J., Kim H.I., Cho H., Yun C.W., Youn J.K., and Park S. Characterization and gene cloning of monoclonal antibody specific for the hepatitis B virus X protein. Hybridoma 19 (2000) 73-80
38. Poussin K., Dienes H., Sirma H., Urban S., Beaugrand M., Franco D., Schirmacher P., Brechot C., and Paterlini Brechot P. Expression of mutated hepatitis B virus X genes in human hepatocellular carcinomas. Int. J. Cancer 80 (1999) 497-505
39. Rost B., Yachdav G., and Liu J. The PredictProtein server. Nucleic Acids Res. 32 (2004) W321-W326
40. Sarin S.K., Thakur V., Guptan R.C., Saigal S., Malhotra V., Thyagarajan S.P., and Das B.C. Profile of hepatocellular carcinoma in India: an insight into the possible etiologic associations. J. Gastroenterol. Hepatol. 16 (2001) 666-673
41. Schaefer S. Hepatitis B virus: significance of genotypes. J. Viral. Hepat. 12 (2005) 111-124
42. Schuster R., Hildt E., Chang S.F., Terradillos O., Pollicino T., Lanford R., Gerlich W.H., Will H., and Schaefer S. Conserved transactivating and pro-apoptotic functions of hepadnaviral X protein in ortho- and avihepadnaviruses. Oncogene 21 (2002) 6606-6613
43. Shinkai N., Tanaka Y., Ito K., Mukaide M., Hasegawa I., Asahina Y., Izumi N., Yatsuhashi H., Orito E., Joh T., and Mizokami M. Influence of hepatitis B virus X, core promoter mutations on hepatocellular carcinoma among patients with subgenotype C2. J. Clin. Microbiol. 45 (2007) 3191-3197
44. Sinha R., Anderson D.E., McDonald S.S., and Greenwald P. Cancer risk and diet in India. J. Postgrad. Med. 49 (2003) 222-228
45. Song B.C., Kim H., Kim S.H., Cha C.Y., Kook Y.H., and Kim B.J. Comparison of full length sequences of hepatitis B virus isolates in hepatocellular carcinoma patients and asymptomatic carriers of Korea. J. Med. Virol. 75 (2005) 13-19
46. Soni K.B., Lahiri M., Chackradeo P., Bhide S.V., and Kuttan R. Protective effect of food additives on aflatoxin-induced mutagenicity and hepatocarcinogenicity. Cancer Lett. 115 (1997) 129-133
47. Sung J.J.Y., Tsui S.K.W., Tse C.H., Ng E.Y.T., Leung K.S., Lee K.H., Mok T.S.K., Bartholomeusz A., Au T.C.C., Tsoi K.K.F., Locarnini S., and Chan H.L.Y. Genotype-specific genomic markers associated with primary hepatomas, based on complete genomic sequencing of hepatitis B virus. J. Virol. 82 (2008) 3604-3611
48. Tan T.L., and Chen W.N. A proteomics analysis of cellular proteins associated with HBV genotype-specific HBX: potential in identification of early diagnostic markers for HCC. J. Clin. Virol. 33 (2005) 293-298
49. Tang H., Oishi N., Kaneko S., and Murakami S. Molecular functions and biological roles of hepatitis B virus X protein. Cancer Sci. 97 (2006) 977-983
50. Terada T., Moriyama M., Uchida T., and Arakawa Y. Nucleotide sequence of the precore/core gene and X gene of hepatitis B virus DNA in asymptomatic hepatitis B virus carrier who are negative for serum hepatitis B core antibody. Intervirology 44 (2001) 243-249
51. Thakur, V., Guptan, R.C., Kazim, S.N., Malhotra, V., Sarin, S.K., 2002. Profile, spectrum and significance of HBV genotypes in chronic liver disease patients in the Indian subcontinent. J Gastroenterol Hepatol 2, 165-170.
52. Tu H., Bonura C., Giannini C., Mouly H., Soussan P., Kew M., Brechot P.P., Brechot C., and Kremsdorf D. Biological impact of natural COOH-terminal deletions of hepatitis B virus X protein in hepatocellular carcinoma tissues. Cancer Res. 61 (2001) 7803-7810
53. Vivekanandan P., Abraham P., Sridharan G., Chandy G., Raghuraman S., Daniel H., and Subramaniam T. Distribution of hepatitis B virus genotypes in blood donors and chronically infected patients in a tertiary care hospital in Southern India. Clin. Infec. Dis. 38 (2004) e81-e86
54. Yeh C.T., Shen C.H., Tai D., Chu C.M., and Liaw Y.F. Identification and characterization of a prevalent hepatitis B virus X protein mutant in Taiwanese patients with hepatocellular carcinoma. Oncogene 19 (2000) 5213-5220